4D Molecular Therapeutics (FDMT) Earnings Date & Reports
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FDMT is expected to report earnings to fall 15.11% to -85 cents per share on February 27
Q4'25
Est.
$-0.86
Q3'25
Est.
$-1.01
Q2'25
Missed
by $0.25
Q1'25
Est.
$-0.86
Q4'24
Missed
by $0.05
The last earnings report on November 10 showed earnings per share of -100 cents, meeting the estimate of -100 cents. With 324.06K shares outstanding, the current market capitalization sits at 587.35M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FDMT showed earnings on November 10, 2025. You can read more about the earnings report here.